Intimation 2020-21
- Change in Directorate
- Clarification on Price Movement
- Appointment of Secretarial Auditor
- Appointment of Statutory Auditor
- Disclosure from Mrs. Vipula J. Choksi
- Grant of Tigecycline Patent by Euracian Patent Office
- Intimation of AGM Book Closure
- Intimation of Amalgamation of Scheme approval by NCLT Ahmedabad
- Intimation of Amalgamation of Scheme approval by NCLT Mumbai
- Intimation of approval of Scheme of Arrangement
- Intimation of no adverse observation letters
- Investor Presentation
- Resignation of Statutory Auditor
- Updates
- Updation on Amalagamation
- Updation on Amalgamation
Intimation 2023-24
- Press Release – DCGI nod for Dalbavancin API and formulation
- Press Release – GMP Certificate from ANVISA, Brazil
- Press Release – Approval from NMPA, China for Prilocaine API
- Clarification on Increase in volume of security
- Press Release – Approval of TGA, Australia and Anvisa, Brazil for Parecoxib 40mg injection
- Intimation of Grant of Patent
- Intimation of Grant of Patent of Addition
- Intimation of Grant of Patent
Intimation 2024-25
- Intimation of demise of Mr. Shrirang Vaidya, Independent Director
- Intimation of retirement of Mrs. Hemal Desai, Head ‐ Taxation
- Clarification on Increase in Volume of Security
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015
- Intimation under Reg 39(3) of SEBI (LODR) Regulation, 2015
- Intimation of Appointment of Dr. Kathiresan Rajasekar as President – International Business
- Intimation of Appointment of Senior Management Personnel
- Intimation of Assessment Order passed by the Assessment Unit, Income Tax Department
- Intimation of Appeal filed against Assessment Order passed by the Assessment Unit, Income Tax Department
- Intimation of Grant of Options under Gufic Biosciences Limited Employee Stock Option Plan 2023 (“Gufic ESOP 2023”)
- Intimation of completion of second term of Dr. Rabi Sahoo (DIN: 01237464), Independent Director of the Company
- Intimation of Grant of Patent in Europe
- Intimation of Incorporation of Company under Section 8 of the Companies Act, 2013 –P S Choksi Foundation
- Intimation of Incorporation of Wholly Owned Subsidiary Company in Dubai, UAE
- Intimation of completion of second term of Mr. Gopal M Daptari (DIN: 07660662), Independent Director of the Company
- Intimation of subscription to equity shares in Veira Life FZE, Wholly Owned Subsidiary in Dubai, UAE
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015